S J Kussick

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi request reprint Using 4-color flow cytometry to identify abnormal myeloid populations
    Steven J Kussick
    University of Washington Department of Laboratory Medicine, Seattle, Wash, USA
    Arch Pathol Lab Med 127:1140-7. 2003
  2. ncbi request reprint A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication
    S J Kussick
    Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
    Leukemia 18:1591-8. 2004
  3. ncbi request reprint Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders
    Steven J Kussick
    Department of Laboratory Medicine, University of Washington, Seattle, USA
    Am J Clin Pathol 120:854-65. 2003
  4. ncbi request reprint 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia
    Brent L Wood
    Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington 98195, USA
    Cytometry B Clin Cytom 72:S14-22. 2007
  5. ncbi request reprint Lineage-specific identification of nonhematopoietic neoplasms by flow cytometry
    Anthony Chang
    University of Washington, Department of Laboratory Medicine, 1959 NE Pacific St, Seattle, WA 98195, USA
    Am J Clin Pathol 119:643-55. 2003
  6. ncbi request reprint Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia
    Steven J Kussick
    Department of Laboratory Medicine, University of Washington, Seattle, USA
    Am J Clin Pathol 124:170-81. 2005
  7. ncbi request reprint Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting
    Jonathan R Fromm
    Department of Laboratory Medicine, University of Washington, WA 98195, USA
    Am J Clin Pathol 126:764-80. 2006
  8. ncbi request reprint Signaling by ectopically expressed Drosophila Src64 requires the protein-tyrosine phosphatase corkscrew and the adapter downstream of receptor kinases
    J A Cooper
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, USA
    Cell Growth Differ 7:1435-41. 1996
  9. ncbi request reprint Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations
    Steven J Kussick
    Department of Laboratory Medicine, University of Washington, Seattle, USA
    Am J Clin Pathol 121:464-72. 2004
  10. ncbi request reprint Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia
    Derek L Stirewalt
    Clinical Research Division, Fred Hutchinson Cancer Research Center, and Division of Oncology, University of Washington, Seattle, WA 98109, USA
    Br J Haematol 124:481-4. 2004

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Using 4-color flow cytometry to identify abnormal myeloid populations
    Steven J Kussick
    University of Washington Department of Laboratory Medicine, Seattle, Wash, USA
    Arch Pathol Lab Med 127:1140-7. 2003
    ....
  2. ncbi request reprint A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication
    S J Kussick
    Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
    Leukemia 18:1591-8. 2004
    ....
  3. ncbi request reprint Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders
    Steven J Kussick
    Department of Laboratory Medicine, University of Washington, Seattle, USA
    Am J Clin Pathol 120:854-65. 2003
    ..In experienced laboratories, 4-color flow cytometry represents a useful method to help distinguish benign from neoplastic marrow in the workup of non-CML MPDs...
  4. ncbi request reprint 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia
    Brent L Wood
    Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington 98195, USA
    Cytometry B Clin Cytom 72:S14-22. 2007
    ..The 2006 Bethesda Consensus conference represents the first successful attempt to define a set of consensus reagents suitable for the initial evaluation of hematopoietic neoplasia...
  5. ncbi request reprint Lineage-specific identification of nonhematopoietic neoplasms by flow cytometry
    Anthony Chang
    University of Washington, Department of Laboratory Medicine, 1959 NE Pacific St, Seattle, WA 98195, USA
    Am J Clin Pathol 119:643-55. 2003
    ....
  6. ncbi request reprint Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia
    Steven J Kussick
    Department of Laboratory Medicine, University of Washington, Seattle, USA
    Am J Clin Pathol 124:170-81. 2005
    ....
  7. ncbi request reprint Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting
    Jonathan R Fromm
    Department of Laboratory Medicine, University of Washington, WA 98195, USA
    Am J Clin Pathol 126:764-80. 2006
    ..FC may offer an alternative to immunohistochemical analysis in confirming the diagnosis of CHL in certain cases, and, through cell sorting, it provides a means of rapidly isolating pure HRS cells...
  8. ncbi request reprint Signaling by ectopically expressed Drosophila Src64 requires the protein-tyrosine phosphatase corkscrew and the adapter downstream of receptor kinases
    J A Cooper
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, USA
    Cell Growth Differ 7:1435-41. 1996
    ..The results are discussed in relation to potential roles for the vertebrate homologues of Drk and Csw (Grb2 and SHP2, respectively) in the transformation of fibroblasts by vertebrate Src...
  9. ncbi request reprint Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations
    Steven J Kussick
    Department of Laboratory Medicine, University of Washington, Seattle, USA
    Am J Clin Pathol 121:464-72. 2004
    ..Our findings add rare cases of follicular hyperplasia to the list of histologically reactive settings in which clonal B-cell populations might be present...
  10. ncbi request reprint Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia
    Derek L Stirewalt
    Clinical Research Division, Fred Hutchinson Cancer Research Center, and Division of Oncology, University of Washington, Seattle, WA 98109, USA
    Br J Haematol 124:481-4. 2004
    ..Novel missense point mutations were found in exon 14, suggesting additional investigations should be performed in AML and other haematopoietic malignancies, using this sensitive technique...
  11. ncbi request reprint Intravascular large B-cell lymphoma involving hemangiomas: an unusual presentation of a rare neoplasm
    Brigitte K Nixon
    Department of Anatomic Pathology, University of Washington Medical Center, Seattle, WA 98195, USA
    Mod Pathol 18:1121-6. 2005
    ..Although this is a rare neoplasm, it is important to consider intravascular large B-cell lymphoma in the differential diagnosis of vascular lesions containing intravascular neoplastic cells...
  12. ncbi request reprint Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease
    Shahid Ahmed
    Saskatoon Cancer Center, University of Saskatchewan Campus, 20 Campus Drive, Saskatoon, SK, Canada S7N4 H4
    Eur J Cancer 40:1320-6. 2004
    ..It appears that BALT lymphoma tends to be localised to lung at the time of diagnosis, responds well to local or systemic therapy, and has a favourable prognosis...